Karen L. Goldenthal, M.D. has joined PharmaNet Development Group’s consulting division as executive director, PharmaNet Consulting. “Dr. Goldenthal’s in-depth knowledge of the clinical and regulatory aspects of vaccine development will bring additional strength and leadership to PharmaNet vaccine development services,” commented James P. Burns, Jr., Ph.D, senior vice president, regulatory consulting worldwide. Dr. Goldenthal joins the company from the FDA where she ...